Medtronic CEO visits Israel

Omar Ishrak heads a delegation of senior executives who will become acquainted with Medtronics recent acquisitions – Mazor Robotics, Nutrino and Visionsense.

Medtronic chairperson and CEO Omar Ishrak today arrived in Israel for a visit at the head of a delegation of Medtronic executives, including EVP and restorative therapy groups president Geoffrey Martha, responsible for the acquisition of Israeli company Mazor Robotics for $1.64 billion.

Medtronic is the world’s largest medical devices company, with $30 billion in annual revenue. Ishrak, who has headed the company since 2011, is a charismatic and an unusual CEO who stands out even among the CEOs of very large companies. The company’s results during his term at the helm have been excellent.

Ishrak’s current visit is aimed at celebrating and getting more thoroughly acquainted with Medtronic’s recent acquisitions, especially the huge (by Israeli standards) acquisition of Mazor; Nutrino, acquired for nearly $100 million; and Visionsense, acquired at a company value of $75 million.

By Globes (Israel)

Image Credit: Medtronic

READ MORE

Avatar
About Peter Coffaro 666 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the orthopedic industry. Recognized by MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager and Distributor. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy and Stryker. He is also the founder of OrthoFeed: a popular blog that covers orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing and professional education. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.